Search research articles
Contact Us
Filters
Showing results (51-60 of 119) with videos related to
Page
of 12
Sort By:
Journal of Biological Response Modifiers
|
October 1, 1990
Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration
F Herrmann, A Ganser, A Lindemann, et al.
Leukemia
|
July 1, 1991
Stable methylation patterns of MYC and other genes regulated during terminal myeloid differentiation
M Lübbert, W Salser, M Prokocimer, et al.
Blood
|
October 15, 1991
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression
F Herrmann, M Andreeff, H J Gruss, et al.
Bone Marrow Transplantation
|
March 1, 1997
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation
S Fetscher, M Lübbert, L Kanz, et al.
Leukemia
|
November 1, 1990
Gamma-interferon interrupts growth stimulation in chronic myelogenous leukemia established by endogenous granulocyte colony-stimulating factor
D Riedel, A Lindemann, J Otto, et al.
Leukemia
|
August 31, 2016
Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDS
H Bertz, M Lübbert, K Ohneberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients
P Wijermans, M Lübbert, G Verhoef, et al.
Bone Marrow Transplantation
|
April 14, 2009
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients
M Lübbert, H Bertz, B Rüter, et al.
Bone Marrow Transplantation
|
September 1, 2009
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
M Lübbert, H Bertz, R Wäsch, et al.
Oncogene
|
February 11, 1992
Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia
M Lübbert, J Mirro, G Kitchingman, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 119) with videos related to
Sort By:
Page
of 12
Journal of Biological Response Modifiers
|
October 1, 1990
Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration
F Herrmann, A Ganser, A Lindemann, et al.
Leukemia
|
July 1, 1991
Stable methylation patterns of MYC and other genes regulated during terminal myeloid differentiation
M Lübbert, W Salser, M Prokocimer, et al.
Blood
|
October 15, 1991
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression
F Herrmann, M Andreeff, H J Gruss, et al.
Bone Marrow Transplantation
|
March 1, 1997
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation
S Fetscher, M Lübbert, L Kanz, et al.
Leukemia
|
November 1, 1990
Gamma-interferon interrupts growth stimulation in chronic myelogenous leukemia established by endogenous granulocyte colony-stimulating factor
D Riedel, A Lindemann, J Otto, et al.
Leukemia
|
August 31, 2016
Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDS
H Bertz, M Lübbert, K Ohneberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients
P Wijermans, M Lübbert, G Verhoef, et al.
Bone Marrow Transplantation
|
April 14, 2009
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients
M Lübbert, H Bertz, B Rüter, et al.
Bone Marrow Transplantation
|
September 1, 2009
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
M Lübbert, H Bertz, R Wäsch, et al.
Oncogene
|
February 11, 1992
Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia
M Lübbert, J Mirro, G Kitchingman, et al.
Page
of 12